1ohen-Zion M,Stepnowsky C,Johnson s,et al.Cognitive changes and sleep disordered breathing in elderly:differences in race[].JPsychosom Res.2004
2Sateia MJ.Neuropsychological impairment and quality of life in obstructive sleep apnea[].C lin ChestMed.2003
3Van Eldik LJ,Wainwright MS.The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain[].Restorative Neurology and Neuroscience.2003
4Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49:1304-1313.
5Kalousova M, Zima T, Tesar V, et al. Relationship between advanced glycoxidation end products, inflammatory markers/acute- phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl, 2003, 84 :S62-S64.
6Liu SX, Hou FF, Guo Z J, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vase Biol, 2006, 26: 1156-1162.
7Skvafilova M, Bulava A, Stejskal D, et al. Increased level of advanced oxidation protein products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palaeky Olomoue Czech Repub,2005, 149:83- 87.
8Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis ,2002, 162:221-225.
9Erol Demirbilek M, Nedret Kilic H, Ferhan Komurcu K, et al. Advanced oxidation protein products in aged with dementia. Am J Immuno1,2007, 3:52-55.
10Kalousova M, Skrha M, Zima TJ. Advanced glycation end- products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res,2002, 51:597-604.
